3Masao O,Jun S, Kunio Y, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan[J]. Hypertens Res,2004,27(2) : 193-202.
1Pedro Marques-Vidal, Elizabeth Mazoyer, Vanina Bongard, et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers[J]. Diabetes Care, 2002,25 : 1371-1377.
2Lin KC, Lin HY, Chou P. Community based epidemiologic study on hyperuricemia and gout in Kin-Hu, Kinmen[J]. J Rheumatol,2000,27:1045-1050.
3National Kidney Foundation-K/DOQI. Clinical practice guidelines for chronic kidney disease: valuation, classification and stratification[J]. Am J Kidney Dis, 2002,39 : S1-266.
4Masao Omura, Jun Saito, Kunio Yamaguchi, et al. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan [J]. Hypertens Res, 2004,27 : 193-202.
5Gordon RD, Stowasser M, Tunny TJ, et al. High incidence of primary aldosteronism in 199 patients referred with hypertension[J]. Clin Exp Pharmacol Physiol, 1994,21: 315-318.
6Textor, Stephen C. Managing renal arterial disease and hypertension[J]. Hypertension, 2003,18 : 260-267.
7Yuji Shigematsu, Mareomi Hamada, Hideki Okayama, et al.Left ventricular hypertrophy precedes other target-organ damagein primary aldosteronism[J]. Hypertension, 1997, 29: 723-727.
8Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends on obesity among US adults, 1999-2000 [J]. JAMA,2002,288:1723-1727.
9Ministry of health and welfare health service bureau: General status of the 4th survey of circulatory diseases (1990). Japanese committee of management and research for circulation disease.1993.
10John E, Hall. The Kidney, hypertension and obesity[J]. Hypertension, 2003,41 : 625-633.
2Stowasser M. Update in primary aldosteronism [ J 1. J Clin Endocrinol Metab ,2009,94(10) :3623-3630.
3Kaplan NM. Primary aldosteronism: evidence against a second epidem- ic[ J]. J Hypertens, 2012,30(10) :1899-1902.
4blosso L, Carvajal C, Gonzolez A, et al. Primary aldosteronism and hy- pertensive disease [ J ]. Hypertension, 2003,42 ( 2 ) : 161-165.
5Conn JW, Cohen EL, Rovner DR, et al. Normokalemic primary aldoste- ronism a detectable cause of curable essential hypertenston [ J ]. JAMA, 1965,193:200-206.
6Hannemann A, Bidlingmaier M, Friedrich N, et al. Screening for prima- ry aldosteronism in hypertensive subjects: results from two German epi- demiological studies[ J]. Eur J Endocrinol, 2012,167 ( 1 ) :7-15.
7PotthoffS A, Beuschlein F, Vonend O. Primay hyperaldosteronism-diag- nostic and treatment [ J ]. Dtsch Med Wochenschr, 2012, 137 ( 48 ) : 2480-2484.
8Acelajado MC, Calhoun DA. Aldosteronism and resitant hypeitension [J]. Int J Hypertens,2011,20( 1 ) :817-820.
9Born-Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular and ce- rebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry[ J]. Clin Endocri- nol Metab ,2009,94 (4) : 1125-1130.
10Acelajado MC, Calhoun DA. Aldosteronism and resitant hypeitension [ J ]. Int J Hypertens,2011,20 ( 1 ) : 817 -820.
